Xijing Qian

1.3k total citations · 1 hit paper
21 papers, 990 citations indexed

About

Xijing Qian is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hepatology. According to data from OpenAlex, Xijing Qian has authored 21 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Hepatology. Recurrent topics in Xijing Qian's work include Mosquito-borne diseases and control (7 papers), Hepatitis C virus research (7 papers) and Viral Infections and Vectors (6 papers). Xijing Qian is often cited by papers focused on Mosquito-borne diseases and control (7 papers), Hepatitis C virus research (7 papers) and Viral Infections and Vectors (6 papers). Xijing Qian collaborates with scholars based in China, Taiwan and United States. Xijing Qian's co-authors include Zhongtian Qi, Chen Xu, Ping Zhao, Yue Wang, Houqi Liu, Kaihong Ji, Yunpeng Zhao, Shuo Fang, Minjuan Wu and Chunyu Xue and has published in prestigious journals such as Journal of Virology, Scientific Reports and Frontiers in Microbiology.

In The Last Decade

Xijing Qian

20 papers receiving 981 citations

Hit Papers

Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exos... 2016 2026 2019 2022 2016 100 200 300 400

Peers

Xijing Qian
Dmitry A. Soloviev United States
Eun Wha Choi South Korea
Keh Chuang Chin Singapore
Chris May United Kingdom
Maryam G. Rohani United States
Xijing Qian
Citations per year, relative to Xijing Qian Xijing Qian (= 1×) peers Ewerton Marques Maggio

Countries citing papers authored by Xijing Qian

Since Specialization
Citations

This map shows the geographic impact of Xijing Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xijing Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xijing Qian more than expected).

Fields of papers citing papers by Xijing Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xijing Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xijing Qian. The network helps show where Xijing Qian may publish in the future.

Co-authorship network of co-authors of Xijing Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Xijing Qian. A scholar is included among the top collaborators of Xijing Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xijing Qian. Xijing Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Chenyang, et al.. (2024). Recent research advances in the development of Dabie Banda virus vaccines. PLoS neglected tropical diseases. 18(8). e0012411–e0012411. 3 indexed citations
2.
Qi, Zhongtian, et al.. (2023). Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development. Viruses. 15(4). 813–813. 14 indexed citations
3.
Ren, Hao, Jiaqi Wang, Xijing Qian, et al.. (2023). Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5. Antiviral Research. 219. 105737–105737. 4 indexed citations
4.
Qian, Xijing, Hailin Tang, Zhenghao Xu, et al.. (2022). Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo. Emerging Microbes & Infections. 11(1). 873–884. 16 indexed citations
5.
Qian, Xijing, et al.. (2022). Synthesis of baicalein derivatives and evaluation of their antiviral activity against arboviruses. Bioorganic & Medicinal Chemistry Letters. 72. 128863–128863. 12 indexed citations
6.
Qian, Xijing, et al.. (2022). Hepatitis C Virus Infection Cycle-Specific MicroRNA Profiling Reveals Stage-Specific miR-4423-3p Targets RIG-I to Facilitate Infection. Frontiers in Cellular and Infection Microbiology. 12. 851917–851917. 4 indexed citations
7.
Qian, Xijing & Zhongtian Qi. (2022). Mosquito-Borne Flaviviruses and Current Therapeutic Advances. Viruses. 14(6). 1226–1226. 31 indexed citations
8.
Qian, Xijing & Zhongtian Qi. (2022). Entry Inhibitors of Hepatitis C Virus. Advances in experimental medicine and biology. 1366. 207–222.
9.
Qian, Xijing, et al.. (2020). SNORD126 Promotes Hepatitis C Virus Infection by Upregulating Claudin-1 via Activation of PI3K-AKT Signaling Pathway. Frontiers in Microbiology. 11. 565590–565590. 15 indexed citations
10.
Qian, Xijing, Wei Zheng, Ying Ma, et al.. (2020). Synthesis and In Vitro anti-HCV and Antitumor Evaluation of Schisandronic Acid Derivatives. Medicinal Chemistry. 17(9). 974–982. 2 indexed citations
11.
Chen, Fei, Xijing Qian, Lin Jia, et al.. (2020). Synthesis and Anti-HCV Activities of 18β-Glycyrrhetinic Acid Derivativesand Their In-Silico ADMET Analysis. Current Computer - Aided Drug Design. 17(6). 831–837. 6 indexed citations
12.
Qian, Xijing, Chen Xu, Ping Zhao, & Zhongtian Qi. (2016). Long non-coding RNA GAS5 inhibited hepatitis C virus replication by binding viral NS3 protein. Virology. 492. 155–165. 58 indexed citations
13.
Qian, Xijing, Xiao‐Lian Zhang, Ping Zhao, et al.. (2016). A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes. Scientific Reports. 6(1). 27268–27268. 16 indexed citations
14.
Qian, Xijing, Yongzhe Zhu, Ping Zhao, & Zhongtian Qi. (2016). Entry inhibitors: New advances in HCV treatment. Emerging Microbes & Infections. 5(1). 1–8. 43 indexed citations
15.
Fang, Shuo, Chen Xu, Yuntong Zhang, et al.. (2016). Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing. Stem Cells Translational Medicine. 5(10). 1425–1439. 455 indexed citations breakdown →
16.
Qian, Xijing, Yongsheng Jin, Hai‐Sheng Chen, et al.. (2016). Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81. Journal of General Virology. 97(5). 1134–1144. 20 indexed citations
17.
Qian, Xijing, Chen Xu, Shuo Fang, et al.. (2016). Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection. Stem Cells Translational Medicine. 5(9). 1190–1203. 128 indexed citations
18.
Xu, Qingqiang, Mingmei Cao, Hongyuan Song, et al.. (2016). Caveolin-1-Mediated Japanese Encephalitis Virus entry Requires a Two-Step Regulation of Actin Reorganization. Future Microbiology. 11(10). 1227–1248. 44 indexed citations
19.
Zhu, Yongzhe, Hao Ren, Qingqiang Xu, et al.. (2015). The Role of Lipid Rafts in the Early Stage of Enterovirus 71 Infection. Cellular Physiology and Biochemistry. 35(4). 1347–1359. 19 indexed citations
20.
Zhu, Yongzhe, Qingqiang Xu, Hao Ren, et al.. (2012). Japanese Encephalitis Virus Enters Rat Neuroblastoma Cells via a pH-Dependent, Dynamin and Caveola-Mediated Endocytosis Pathway. Journal of Virology. 86(24). 13407–13422. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026